계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Cypre
company
About
Cypre Inc. is a biotechnology company.
- 11 - 50
Highlights
Details
- Last Funding Type
- Convertable Note
- Industries
- Biotechnology,Life Science,Therapeutics
- Founded date
- Jan 1, 2016
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Cypre is dedicated to overcoming therapeutic resistance for cancer patients. They are applying the platform with therapeutic innovators for drug discovery and combination screening across various modalities.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Cypre has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Jul 15, 2018 from a Convertable Note round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 15, 2018 | Convertable Note | — | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Cypre is funded by 2 investors.
The Next Impact
and Novit Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
The Next Impact
|
— | Convertable Note |
|
|
— | Convertable Note |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
